| [1] |
Augello A,Kurth TB,De Bari C.Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches[J].Eur Cell Mater,2010,20:121-133. http://cn.bing.com/academic/profile?id=2107989515&encoded=0&v=paper_preview&mkt=zh-cn
|
| [2] |
Bassi EJ, Aita CA,Cmara NO. Immune regulatory properties of multipotent mesenchymal stromal cells: where do we stand?[J]. World J Stem Cells,2011,3(1):1-8. doi: 10.4252/wjsc.v3.i1.1
|
| [3] |
Lv FJ,Tuan RS,Cheung KM, et al. Concise review: the surface markers and identity of human mesenchymal stem cells[J].Stem Cells,2014,32(6):1408-1419. doi: 10.1002/stem.1681
|
| [4] |
DelaRosa O,Lombardo E. Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential[J].Mediators Inflamm,2010:865601. http://cn.bing.com/academic/profile?id=2005349078&encoded=0&v=paper_preview&mkt=zh-cn
|
| [5] |
François M, Romieu-Mourez R, Li M, et al. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation[J]. Mol Ther,2012,20(1):187-195. doi: 10.1038/mt.2011.189
|
| [6] |
Kariminekoo S, Movassaghpour A, Rahimzadeh A, et al. Implications of mesenchymal stem cells in regenerative medicine[J]. Artif Cells Nanomed Biotechnol,2016,44(3):749-757. doi: 10.3109/21691401.2015.1129620
|
| [7] |
Tasso R, Ilengo C, Quarto R, et al. Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis[J]. Invest Ophthalmol Vis Sci, 2012, 53(2):786-793. doi: 10.1167/iovs.11-8211
|
| [8] |
Fontaine MJ, Shih H, Schfer R, et al. Unraveling the mesenchymal stromal cells' paracrine immunomodulatory effects[J]. Transfus Med Rev,2016,30(1):37-43. doi: 10.1016/j.tmrv.2015.11.004
|
| [9] |
Chatterjee D, Marquardt N, Tufa DM, et al. Human umbilical cord-derived mesenchymal stem cells utilize activin-A to suppress interferon-γ production by natural killer cells[J]. Front Immunol, 2014, 5:662. http://cn.bing.com/academic/profile?id=2049111133&encoded=0&v=paper_preview&mkt=zh-cn
|
| [10] |
Qu X, Liu X, Cheng K, et al. Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion[J].Exp Hematol,2012,40(9):761-770. doi: 10.1016/j.exphem.2012.05.006
|
| [11] |
Choi H, Lee RH, Bazhanov N, et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan- induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages[J].Blood,2011,118(2):330-338. doi: 10.1182/blood-2010-12-327353
|
| [12] |
Wang N, Li Q, Zhang L, et al. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6[J]. PLoS One,2012,7(8):e43768. doi: 10.1371/journal.pone.0043768
|
| [13] |
Liu Y, Yin Z, Zhang R, et al. MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6[J]. Biochem Biophys Res Commun, 2014, 450(4):1409-1415. doi: 10.1016/j.bbrc.2014.07.001
|
| [14] |
Wang D, Huang S, Yuan X, et al. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus[J]. Cell Mol Immunol, 2015,DOI: 10.1038/cmi.2015.89[Epub ahead of print].
|
| [15] |
Luz-Crawford P, Djouad F, Toupet K, et al. Mesenchymal stem cell-derived interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation[J]. Stem Cells,2016,34(2):483-492. doi: 10.1002/stem.2254
|
| [16] |
Mougiakakos D, Jitschin R, Johansson CC, et al. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells[J].Blood,2011,117(18):4826-4835. doi: 10.1182/blood-2010-12-324038
|
| [17] |
Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system[J].Nat Rev Immunol, 2012,12(5):383-396. doi: 10.1038/nri3209
|
| [18] |
Melief SM, Schrama E, Brugman MH, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages[J]. Stem Cells,2013,31(9):1980-1991. doi: 10.1002/stem.1432
|
| [19] |
Geng Y, Zhang L, Fu B, et al. Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages[J].Stem Cell Res Ther,2014,5(3):80. doi: 10.1186/scrt469
|
| [20] |
Brandau S, Jakob M, Hemeda H, et al. Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge[J]. J Leukoc Biol,2010,88(5):1005-1015. doi: 10.1189/jlb.0410207
|
| [21] |
Hall SR, Tsoyi K, Ith B, et al. Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils[J]. Stem Cells, 2013, 31(2):397-407. doi: 10.1002/stem.v31.2
|
| [22] |
Spaggiari GM, Moretta L. Cellular and molecular interactions of mesenchymal stem cells in innate immunity[J]. Immunol Cell Biol,2013, 91(1):27-31. doi: 10.1038/icb.2012.62
|
| [23] |
Moll G, Jitschin R, von Bahr L, et al. Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses[J]. PLoS One,2011，6(7):e21703. doi: 10.1371/journal.pone.0021703
|
| [24] |
Tu Z, Li Q, Bu H, et al. Mesenchymal stem cells inhibit complement activation by secreting factor H[J].Stem Cells Dev,2010, 19(11):1803-1809. doi: 10.1089/scd.2009.0418
|
| [25] |
Li Y, Lin F. Mesenchymal stem cells are injured by complement after their contact with serum[J].Blood,2012, 120(17):3436-3443. doi: 10.1182/blood-2012-03-420612
|
| [26] |
Najar M, Raicevic G, Fayyad-Kazan H, et al. Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming[J].Stem Cell Rev,2012,8(4):1188-1198. doi: 10.1007/s12015-012-9408-1
|
| [27] |
Briones J, Novelli S, Sierra J. T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications[J].Bone Marrow Res,2011:976793. http://cn.bing.com/academic/profile?id=2065828375&encoded=0&v=paper_preview&mkt=zh-cn
|
| [28] |
Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli[J]. Blood,2002,99(10):3838-3843. doi: 10.1182/blood.V99.10.3838
|
| [29] |
Su J, Chen X, Huang Y, et al. Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species[J].Cell Death Differ,2014,21(3):388-396. doi: 10.1038/cdd.2013.149
|
| [30] |
Saldanha-Araujo F, Ferreira FI, Palma PV, et al. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes[J]. Stem Cell Res,2011,7(1):66-74. doi: 10.1016/j.scr.2011.04.001
|
| [31] |
Majumdar MK, Keane-Moore M, Buyaner D, et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells[J].J Biomed Sci,2003,10(2):228-241. doi: 10.1007/BF02256058
|
| [32] |
Ren G, Zhao X, Zhang L, et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression[J].J Immunol,2010,184(5):2321-2328. doi: 10.4049/jimmunol.0902023
|
| [33] |
de Mare-Bredemeijer EL, Mancham S, Verstegen MM, et al. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses[J]. Stem Cells Dev,2015,24(12):1436-1447. doi: 10.1089/scd.2014.0485
|
| [34] |
Najar M, Raicevic G, Boufker HI, et al. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor[J]. Tissue Eng Part A,2010,16(11):3537-3546. doi: 10.1089/ten.tea.2010.0159
|
| [35] |
Del Papa B, Sportoletti P, Cecchini D, et al. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction[J]. Eur J Immunol,2013,43(1):182-187. doi: 10.1002/eji.201242643
|
| [36] |
Li J, Zhuan-sun YX, Wen B,et al. Human mesenchymal stem cells elevate CD4+CD25+CD127low/- regulatory T cells of asthmatic patients via heme oxygenase-1[J]. Iran J Allergy Asthma Immunol,2013,12(3):228-235. http://cn.bing.com/academic/profile?id=2118259656&encoded=0&v=paper_preview&mkt=zh-cn
|
| [37] |
Yan Z, Zhuansun Y, Chen R, et al. Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism[J].Exp Cell Res,2014,324(1):65-74. doi: 10.1016/j.yexcr.2014.03.013
|
| [38] |
Rosado MM, Bernardo ME, Scarsella M, et al. Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells[J].Stem Cells Dev,2015, 24(1):93-103. doi: 10.1089/scd.2014.0155
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: